Join the 155,000+ IMP followers

www.medical-devices.tech
Dassault Systemes News

DASSAULT SYSTÈMES: MEDIDATA DRIVES DIVERSITY IN CLINICAL TRIALS

Medidata has set a milestone by passing 30,000 clinical trials and 9 million study participants.

DASSAULT SYSTÈMES: MEDIDATA DRIVES DIVERSITY IN CLINICAL TRIALS

Known for its ground-breaking technological innovations in clinical trials, Medidata, a Dassault Systèmes company, has exceeded 30,000 clinical trials and 9 million study participants. These milestones, achieved together with more than 2,100 global customers and partners, have been fueled by Medidata’s platform and life sciences solutions that power smarter treatments and healthier people, while driving greater access to trials.

Medidata has the deepest, widest platform of pioneering programs including decentralized clinical trials, increasing diversity in clinical studies, advanced AI solutions for trial design and simulation, site selection, and Synthetic Control Arms. And Medidata technologies and services are driving more value for customers, helping reach critical development milestones faster, including saving an average of one month in study build time and two months in conducting studies.

Leveraging this volume of trials, patients and data, Medidata delivers unmatched results in the industry. With studies conducted in more than 140 countries, Medidata is involved in nearly 40% of company-initiated trial starts globally. Approximately 70% of novel drugs approved by the U.S. Food and Drug Administration (FDA) in 2022 were developed with Medidata software. And in the critical area of rare disease research, Medidata has supported more than 2,000 studies representing more than 320,000 participants.

www.3ds.com

  Ask For More Information…

LinkedIn
Pinterest

Join the 155,000+ IMP followers

International